Be resolute! In the era of digital economy, the application field of China's software industry is leading the trend Post date May 15, 2022 — 17:52 Post Lock Read More Chaoxun Communications Board Secretary: The loss in 2021 is mainly due to the sharp decline in the performance of the controlled subsidiary and the company's provision for asset impairment losses. Post date May 13, 2022 — 20:08 Post Lock Read More 11 days and 10 boards, it went crazy! The revenue hit a new high in 5 years, but netizens said: "Chicken feathers in one place, sooner or later!" what happened? -Stock Channel-Hexun.com Post date May 13, 2022 — 17:30 Post Lock Read More Watching the market: Hongtao shares and other 6 stocks stopped in seconds CFi.CN Zhongcai Network Post date May 12, 2022 — 10:35 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Policies to provide warmth can be expected to stabilize, the real estate industry is waiting for flowers to bloom-Pyeongchang Real Estate Information Network Post date May 8, 2022 — 17:01 Post Lock Read More Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Chaoxun Communications Board Secretary: The loss in 2021 is mainly due to the sharp decline in the performance of the controlled subsidiary and the company's provision for asset impairment losses. Post date May 13, 2022 — 20:08 Post Lock Read More 11 days and 10 boards, it went crazy! The revenue hit a new high in 5 years, but netizens said: "Chicken feathers in one place, sooner or later!" what happened? -Stock Channel-Hexun.com Post date May 13, 2022 — 17:30 Post Lock Read More Watching the market: Hongtao shares and other 6 stocks stopped in seconds CFi.CN Zhongcai Network Post date May 12, 2022 — 10:35 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Policies to provide warmth can be expected to stabilize, the real estate industry is waiting for flowers to bloom-Pyeongchang Real Estate Information Network Post date May 8, 2022 — 17:01 Post Lock Read More Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
11 days and 10 boards, it went crazy! The revenue hit a new high in 5 years, but netizens said: "Chicken feathers in one place, sooner or later!" what happened? -Stock Channel-Hexun.com Post date May 13, 2022 — 17:30 Post Lock Read More Watching the market: Hongtao shares and other 6 stocks stopped in seconds CFi.CN Zhongcai Network Post date May 12, 2022 — 10:35 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Policies to provide warmth can be expected to stabilize, the real estate industry is waiting for flowers to bloom-Pyeongchang Real Estate Information Network Post date May 8, 2022 — 17:01 Post Lock Read More Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Watching the market: Hongtao shares and other 6 stocks stopped in seconds CFi.CN Zhongcai Network Post date May 12, 2022 — 10:35 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Policies to provide warmth can be expected to stabilize, the real estate industry is waiting for flowers to bloom-Pyeongchang Real Estate Information Network Post date May 8, 2022 — 17:01 Post Lock Read More Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Policies to provide warmth can be expected to stabilize, the real estate industry is waiting for flowers to bloom-Pyeongchang Real Estate Information Network Post date May 8, 2022 — 17:01 Post Lock Read More Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Policies to provide warmth can be expected to stabilize, the real estate industry is waiting for flowers to bloom-Pyeongchang Real Estate Information Network Post date May 8, 2022 — 17:01 Post Lock Read More Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Policies to provide warmth can be expected to stabilize, the real estate industry is waiting for flowers to bloom-Pyeongchang Real Estate Information Network Post date May 8, 2022 — 17:01 Post Lock Read More Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets Innovative Drugs｜Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Policies to provide warmth can be expected to stabilize, and the real estate industry is waiting for flowers to bloom Post date May 7, 2022 — 17:48 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! -Hong Kong stocks-financial sector Post date May 6, 2022 — 15:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold"! Junshi Biology_Sina Finance_Sina.com Post date May 6, 2022 — 14:03 Post Lock Read More During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
During the in-depth adjustment period, research institutions are keen to tap potential opportunities. Junshi Bio has been "crossed the threshold" Post date May 6, 2022 — 12:53 Post Lock Read More Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zhengyan sees the disk: There should be two major reasons for the emotional preference to buy on dips – yqqlm Post date May 6, 2022 — 08:38 Post Lock Read More Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yang Delong: The Fed's interest rate hike boots landing multiple policies are good to boost market confidence Fund Channel Hexun Network Post date May 5, 2022 — 21:49 Post Lock Read More Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hang Seng Index closed down 0.36% at 20793, property stocks were under pressure, Ronshine China (03301) fell 9.38%_ Finance & Economics Post date May 5, 2022 — 19:45 Post Lock Read More In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
In 2022, it is difficult to have a job! -News Channel-Hexun.com Post date May 2, 2022 — 23:52 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More
Caishen.CoCaishen.Co